Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 19133659)

1.

FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.

Wider C, Dachsel JC, Soto AI, Heckman MG, Diehl NN, Yue M, Lincoln S, Aasly JO, Haugarvoll K, Trojanowski JQ, Papapetropoulos S, Mash D, Rajput A, Rajput AH, Gibson JM, Lynch T, Dickson DW, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Mov Disord. 2009 Feb 15;24(3):455-9. doi: 10.1002/mds.22442.

2.

[Analysis of the rs12720208 single-nucleotide polymorphism of the FGF20 gene in Russian patients with sporadic Parkinson's disease].

Ustinova VV, Shadrina MI, Fedotova EIu, Illarioshkin SN, Limborskaia SA, Slominskiĭ PA.

Genetika. 2012 Dec;48(12):1437-9. Russian.

PMID:
23516905
3.

FGF20 rs12720208 SNP and microRNA-433 variation: no association with Parkinson's disease in Spanish patients.

de Mena L, Cardo LF, Coto E, Miar A, Díaz M, Corao AI, Alonso B, Ribacoba R, Salvador C, Menéndez M, Morís G, Alvarez V.

Neurosci Lett. 2010 Jul 19;479(1):22-5. doi: 10.1016/j.neulet.2010.05.019. Epub 2010 May 13.

PMID:
20471450
4.

Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease.

Mizuta I, Tsunoda T, Satake W, Nakabayashi Y, Watanabe M, Takeda A, Hasegawa K, Nakashima K, Yamamoto M, Hattori N, Murata M, Toda T.

Hum Genet. 2008 Aug;124(1):89-94. doi: 10.1007/s00439-008-0525-5. Epub 2008 Jun 22.

PMID:
18568448
5.

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein.

Wang G, van der Walt JM, Mayhew G, Li YJ, Züchner S, Scott WK, Martin ER, Vance JM.

Am J Hum Genet. 2008 Feb;82(2):283-9. doi: 10.1016/j.ajhg.2007.09.021. Epub 2008 Jan 31.

6.

Fibroblast growth factor 20 (FGF20) polymorphism is a risk factor for Parkinson's disease in Chinese population.

Pan J, Li H, Wang Y, Ma JF, Zhang J, Wang G, Liu J, Wang XJ, Xiao Q, Chen SD.

Parkinsonism Relat Disord. 2012 Jun;18(5):629-31. doi: 10.1016/j.parkreldis.2012.01.017. Epub 2012 Feb 18.

PMID:
22342445
7.

Fibroblast growth factor 20 polymorphism in sporadic Parkinson's disease in Northern Han Chinese.

Xu X, Wang N, Xu H, Xie A, Jiang H, Xie J.

J Clin Neurosci. 2013 Nov;20(11):1588-90. doi: 10.1016/j.jocn.2013.02.023. Epub 2013 Aug 9.

PMID:
23938014
8.

Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients.

Clarimon J, Xiromerisiou G, Eerola J, Gourbali V, Hellström O, Dardiotis E, Peuralinna T, Papadimitriou A, Hadjigeorgiou GM, Tienari PJ, Singleton AB.

BMC Neurol. 2005 Jun 20;5:11.

9.

Fibroblast growth factor 20 gene and Parkinson's disease in the Japanese population.

Satake W, Mizuta I, Suzuki S, Nakabayashi Y, Ito C, Watanabe M, Takeda A, Hasegawa K, Sakoda S, Yamamoto M, Hattori N, Murata M, Toda T.

Neuroreport. 2007 Jun 11;18(9):937-40.

PMID:
17515805
10.

alpha-Synuclein promoter RsaI T-to-C polymorphism and the risk of Parkinson's disease.

Wang CK, Chen CM, Chang CY, Chang KH, Chen IC, Li ML, Lee-Chen GJ, Wu YR.

J Neural Transm. 2006 Oct;113(10):1425-33. Epub 2006 Apr 11.

PMID:
16604306
11.

Genetic variation in FGF20 modulates hippocampal biology.

Lemaitre H, Mattay VS, Sambataro F, Verchinski B, Straub RE, Callicott JH, Kittappa R, Hyde TM, Lipska BK, Kleinman JE, McKay R, Weinberger DR.

J Neurosci. 2010 Apr 28;30(17):5992-7. doi: 10.1523/JNEUROSCI.5773-09.2010.

12.

Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population.

Rajput A, Vilariño-Güell C, Rajput ML, Ross OA, Soto-Ortolaza AI, Lincoln SJ, Cobb SA, Heckman MG, Farrer MJ, Rajput A.

Mov Disord. 2009 Dec 15;24(16):2411-4. doi: 10.1002/mds.22795.

PMID:
19890971
13.

Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material.

Westerlund M, Belin AC, Anvret A, Håkansson A, Nissbrandt H, Lind C, Sydow O, Olson L, Galter D.

FASEB J. 2008 Oct;22(10):3509-14. doi: 10.1096/fj.08-110148. Epub 2008 Jul 7.

14.

Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.

Kobayashi H, Ujike H, Hasegawa J, Yamamoto M, Kanzaki A, Sora I.

Mov Disord. 2006 Dec;21(12):2157-64.

PMID:
17078049
15.

Association of polymorphism in rs2736990 of the α-synuclein gene with Parkinson's disease in a Chinese population.

Pan F, Ding H, Dong H, Ye M, Liu W, Cui G, Chen J, Wu Y, Wang H, Dai X, Shi H, Ding X.

Neurol India. 2013 Jul-Aug;61(4):360-4. doi: 10.4103/0028-3886.117595.

16.

Gene-gene interaction between FGF20 and MAOB in Parkinson disease.

Gao X, Scott WK, Wang G, Mayhew G, Li YJ, Vance JM, Martin ER.

Ann Hum Genet. 2008 Mar;72(Pt 2):157-62. doi: 10.1111/j.1469-1809.2007.00418.x. Epub 2008 Jan 20.

PMID:
18205889
17.

[The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility].

Zhao XP, Zheng HM, Xie HJ, Ding SJ, Ren DM.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Aug;21(4):339-41. Chinese.

PMID:
15300629
18.

Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.

Chiba-Falek O, Lopez GJ, Nussbaum RL.

Mov Disord. 2006 Oct;21(10):1703-8.

PMID:
16795004
19.

Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease.

van der Walt JM, Noureddine MA, Kittappa R, Hauser MA, Scott WK, McKay R, Zhang F, Stajich JM, Fujiwara K, Scott BL, Pericak-Vance MA, Vance JM, Martin ER.

Am J Hum Genet. 2004 Jun;74(6):1121-7. Epub 2004 Apr 30.

20.

Alpha-synuclein repeat variants and survival in Parkinson's disease.

Chung SJ, Biernacka JM, Armasu SM, Anderson K, Frigerio R, Aasly JO, Annesi G, Bentivoglio AR, Brighina L, Chartier-Harlin MC, Goldwurm S, Hadjigeorgiou G, Jasinska-Myga B, Jeon BS, Kim YJ, Krüger R, Lesage S, Markopoulou K, Mellick G, Morrison KE, Puschmann A, Tan EK, Crosiers D, Theuns J, Van Broeckhoven C, Wirdefeldt K, Wszolek ZK, Elbaz A, Maraganore DM; Genetic Epidemiology of Parkinson's Disease Consortium.

Mov Disord. 2014 Jul;29(8):1053-7. doi: 10.1002/mds.25841. Epub 2014 Feb 27.

PMID:
24578302
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk